For those who struggle day-to-day with constant pain from chronic medical conditions, a vape pen can be the perfect way to discreetly provide instant relief with less lung inflammation than traditional flame-to-flower combustion.
Vaping heats cannabis, rather than burning it, so there is no combustion and no smoke, which makes it the preferred method for a lot of users.
Unfortunately, the cannabis vaping industry is facing a crisis that could make it difficult for patients to receive their medicine.
Mail Ban Categorizes Vaporizing Devices as Nicotine Product
Concealed in last December’s federal bill, a new law banned the USPS delivery of vape products. This caused reputable cannabis vaporizer companies to struggle delivering products to their customers.
Due to the broad wording of the law, this generalizes any vaporizing device as a nicotine product, which will consequently cause shippers to maneuver through a strenuous list of mandatory requirements.
The Preventing Online Sales Of E-Cigarettes to Children Act calls for vape companies to follow the Prevent All Cigarette Trafficking (PACT) Act.
PACT contains a list of strict rules and regulations that vape manufactures must follow. This includes:
- Registering with the U.S. Attorney General
- Confirming the age of customers
- If shipping to a state that taxes cigarettes and smokeless tobacco, businesses are required to apply to the federal government and the tobacco tax administrators of the states.
- Keep thorough documentation of all names and addresses that the product was sold, as well as the quantities sold.
- Keep a record for five years of all of the times a delivery was interrupted due to the buyer of the delivery violating the PACT Act.
The strict language of the PACT act includes serious repercussions if a regulation isn’t followed, including prison time. This will cause a domino effect of hardship for vaporizer companies.
Hundreds of vaporizer businesses could close, and dwindling direct-to-consumer sales will force consumers to seek other means to obtain their medicine.
Published: March 22, 2021
Founder & Interim Editor of L.A. Cannabis News